Plain-English translation of NCT07023289 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new investigational medication called for colorectal cancer patients who have completed initial surgery and chemotherapy but show early warning signs (detected through a blood test) that cancer might come back, even though imaging scans show no visible tumors. The study will compare this medication given alone versus the current standard treatment to see which approach works better at preventing cancer recurrence.
Colorectal cancer sometimes returns even after surgery and chemotherapy, but doctors can now detect these early warning signs through blood tests before any tumors become visible on scans. This medication is being tested to see if it can prevent cancer from coming back in these high-risk patients.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the new investigational medication through IV infusions or your standard treatment. You will attend regular clinic visits over approximately 4 years for blood tests, imaging scans, and side effect monitoring. The trial involves more frequent appointments and testing than typical standard care, so you should be prepared for a higher treatment schedule.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States